Navigation Links
Biotech Group Warns Proposed Medicare Cuts Could Hurt Critical Sector of New England Economy
Date:7/28/2011

WAKEFIELD, Mass. July 28, 2011 /PRNewswire/ -- As the fight over deficit reform continues to drag on in Washington, the New England Biotech Association (NEBA) is urging lawmakers from across the region to fight to save a critical sector of the New England economy and ensure it doesn't become a victim of short-sighted cuts.

"Proposed cuts to Medicare not only reduce options for treatment and medications available to seniors, but would require seniors to pay more for less coverage," said NEBA Chairman Paul Pescatello.   "The biopharmaceutical industry in New England brings in jobs and research dollars, so we need our federal representatives to stand up now and fight against drastic Medicare cuts that will hurt the industry and its search for miracle cures."  

"While the growing federal deficit is certainly a threat to our economy, many of the proposed Medicare cuts would be devastating to the millions of Americans counting on that coverage in the coming years and to biotech jobs in our region," said Pescatello.  "Discussion about importing price controls into Medicare is especially distressing, as it will reduce competition, stifle development, and lead to poorer treatment quality for seniors."

Pescatello noted that more than a hundred members of Congress, including U.S. representative Frank Guinta (R-NH) and Charles Bass (R-NH) have written to Secretary of Health and Human Services Kathleen Sebelius urging her to protect Medicare Part D, which provides a competitive marketplace for private prescription drug insurance and provides pricing competition.

About NEBA:

Representing over 600 members from all six New England states, NEBA is committed to educating policy makers and the public about the biotech industry; promoting public policies that foster innovation; encouraging economic development in the biotech sector; and advocating continued patient access to life-saving and life-improving breakthrough biotechnology medicines.  

To find out more about NEBA, visit www.newenglandbiotech.org.


'/>"/>
SOURCE New England Biotech Association
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. TriLink BioTechnologies, Inc. Announces License Agreement with Lucigen Corporation
2. Robin Powell Becomes President at Biotech Leader Divine Skin (DSKX)
3. FDA Issues Complete Response Letter to Janssen Biotech, Inc. for SIMPONI® Supplemental Biologic License Application
4. Summer Street Research Announces Expansion of Research Team with the Addition of Ling Wang, CFA, Senior Biotechnology Analyst
5. Industrial Biotechnology China News 1106
6. Phalanx Biotech Group Launches Rice Genome OneArray®
7. Axial Biotech Signs Agreement With Shriners Hospital for Children
8. Alacrita Asks "Are We All Biotech Now?"
9. Wound Management Technologies Webcasting Live from OneMedForum NY Biotech Conference on Thursday, June 23 at 10 am EDT
10. Reportlinker Adds White Biotechnology
11. New Jersey Targets Life-Sciences Investors at Worlds Largest Biotechnology Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)...  According to Kalorama Information, the dominant trends ... include significant efforts in automation as well as ... affordable sequencers, say the healthcare market research firm, ... sample prep materials.  The healthcare market research company,s ... Next Generation Sequencing (NGS) , highlights major trends ...
(Date:6/22/2016)... DIEGO , June 22, 2016   ViaCyte, ... first pluripotent stem cell-derived islet replacement therapy for the ... presentations at ISSCR 2016 Annual Meeting.  ISSCR 2016, the ... to 25th at Moscone West in San Francisco.  ... of the presentations are as follows:Event: , Focus Session: ...
(Date:6/22/2016)... 2016  Mesa Biotech Inc., a privately-held, molecular ... designed specifically for point-of-care (POC) infectious disease diagnosis, ... board (SAB). Approved by the executive leadership team ... to advise on the development and commercialization of ... Dr. Steve Young , this world-class team ...
(Date:6/21/2016)... China , June 22, 2016 /PRNewswire/ ... 2 clinical trial for its novel patch product AB001 ... and clinically meaningful pain relief against placebo. Conducted at ... , the trial enrolled 146 patients with chronic ... analgesia against placebo at week-1 (p=0.024), (2) greater reduction ...
Breaking Biology Technology:
(Date:6/2/2016)... Perimeter Surveillance & Detection Systems, ... Infrastructure, Support & Other Service  The latest ... comprehensive analysis of the global Border Security market ... of $17.98 billion in 2016. Now: In ... in software and hardware technologies for advanced video surveillance. ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
Breaking Biology News(10 mins):